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Abstract 
Purpose: Increased complexity of interventional radiotherapy (brachytherapy – BT) treatment planning and qual-
ity control procedures has led to the need of a specific training. However, the details of the features of BT learning 
objectives and their distribution in the training paths of the Italian Radiation Oncology Schools are not known. This 
paper aims to provide the actual ‘state-of-the-art’ of BT education in Italy and to stimulate the debate on this issue. 
Material and methods: All the Italian radiation oncology schools’ directors (SD) were involved in a web survey, 
which included questions on the teaching of BT, considering also the 2011 ESTRO core curriculum criteria. The sur-
vey preliminary results were discussed at the 8th Rome INTER-MEETING (INTERventional Radiotherapy Multidis-
ciplinary Meeting), June 24th, 2017. The present paper describes the final results of the survey and possible future 
teaching strategies resulting from the discussion. 
Results: A total of 23 SDs answered the survey. The results evidenced a wide heterogeneity in the learning activities 
available to trainees in BT across the country. While theoretical knowledge is adequately and homogeneously transmit-
ted to trainees, the types of practice to which they are exposed varies significantly among different schools. 
Conclusions: This survey proves the need for an improvement of practical BT education in Italy and the advis-
ability of a national BT education programme networking schools of different Universities. Beside the organization of 
national/international courses for BT practical teaching, Universities may also establish post-specialization courses 
(‘second level’ Masters) to allow professionals (already certified in radiation oncology) to acquire more advanced BT 
knowledge. 
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An increased level of complexity in BT treatment 
planning and quality control procedures has led to the 
need of specific training. To promote high-level and stan-
dardized training, the European Society for Radiotherapy 
and Oncology (ESTRO) included high-level knowledge 
of BT in the ESTRO core 2011 curricula [3]. Recently, the 
Italian Association of Radiation Oncology (AIRO) has 
published the results of a survey regarding the availabil-
ity of BT equipment and the type of services offered in 
the various Italian hospitals [4]. However, it seems useful 
to understand also the ‘state-of-the-art’ about training in 
BT during residency, especially because, in Italian legis-
lation, BT practical teaching is included among the mini-
mum requirements for the accreditation of radiation on-
cology schools [5,6]. However, the features of BT learning 
objectives and their distribution in the training paths of 
Italian radiation oncology schools are not known in detail 
in the Italian context. Therefore, this paper aims to pro-
vide some information about the actual ‘state-of-the-art’ 
of BT education in Italy, in the light of the 2011 ESTRO 
core curricula, and to stimulate the debate on this issue. 
It was realized within the frame of the activities of the 
INTErventional Radiotherapy ACtive Teaching School 
(INTERACTS), which declare its mission in the interven-
tional RT education and research [7,8]. 
Material and methods 
All the Italian radiation oncology schools’ directors (SD) 
were involved in a web survey, which considered the sug-
gestions of the 2011 ESTRO core curricula criteria [3]. To 
achieve maximum participation, the survey was distributed 
among the participants in two rounds (June 2017 and Febru-
Purpose 
Rapid evolution and improvement of technology in 
radiation oncology and the complexity of each area of ra-
diotherapy (RT) practice determined the need for an ade-
quate and flexible practical training system. In the field of 
interventional radiotherapy (brachytherapy – BT), a de-
cline in BT utilization was detected in the 1990’s, essen-
tially due to technological improvement of external beam 
RT. However, since 2004, a new increase in BT treatments 
was observed, possibly due to developments in BT plan-
ning and delivery [1,2]. 
Table 1. Five questions on general issue and their 
possible answers
1.	 Regarding	 BT	 teaching	 and	 evaluation,	 teaching	 is	mostly	
carried	 out	 by	 (more	 than	 one	 answer):	 faculty	 radiation	
oncologists	(ROs),	faculty	ROs	specialist	in	BT,	physicists,	fel-
lows,	senior	residents,	outside	experts	
2.	The	most	common	forms	of	BT	teaching	are	(more	than	one	
answer):	informal	lectures,	didactic	lectures,	problem-based	
approaches,	 senior	 resident	 presentations,	 simulation,	 on	
site	teaching,	on	site	teaching	dosimetry,	courses	
3.	Your	center	has	defined	specific	written	objectives	with	re-
spect	to	knowledge,	skills,	and	required	attitudes	for	a	resi-
dent	to	be	competent	in	BT?	Yes	(based	on	ESTRO	core	cur-
riculum),	No	
4.	Formal	evaluations	of	practical	skills	are	mostly	carried	out	
by	(more	than	one	answers):	direct	observation,	oral	exam-
inations,	written	examinations,	no	formal	evaluation	
5.	The	main	barriers	to	BT	teaching	are:	lack	of	clinical	practice,	
lack	of	time,	other	
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ary 2018). As the survey was blinded, in the second submis-
sion, we requested the SDs who had already responded to 
the first submission not to reply again. The survey contained 
seven questions in English and was hosted by SurveyMon-
key (www.surveymonkey.com). The names of respondents 
were blinded to the authors of this paper. 
Five questions (Table 1) were on general issues; one 
(including multiple items) considered the specific skills the 
resident should gain (Table 2). One key question aimed at 
acquiring information on the availability of the different BT 
procedures in the academic hospital where the school was 
based or in other structures within the school’s network. 
Respondents were also asked to declare which procedures, 
in their opinion, should be a part of the resident’s training. 
The listed anatomical disease sites treated with BT included 
gynecological area, prostate (high-dose-rate and low-dose-
rate), skin, breast, esophagus, head & neck site, lung (endo-
bronchial), different sites of soft tissue sarcoma, eye, rectum, 
anus as well as different sites of BT in children. 
The survey preliminary results were discussed on 
24th June 2017 in a dedicated session of the 8th ROME 
INTER-MEETING (ROME INTErventional Radiotherapy 
Multidisciplinary Meeting). The present paper describes 
the results of the survey and future strategies resulting 
from the discussion. 
Results 
In June 2017, they were 25 of Italian radiotherapy 
schools, while in February 2018 – 23 schools. A total of 
23 SDs responded to the survey. 
The questionnaire results showed that BT teaching is 
mainly done by board certified ROs, experienced and active-
ly practicing BT (76%, 16 out of 21 responders, 2 responders 
skipped the question) and to a lesser extent by other faculty 
ROs (57%, 12 responders), physicist (38%, 8 responders) as 
well as occasionally senior residents or invited external ex-
perts were involved in brachytherapy education. 
Table 2. A question on the level of skills acquisition 
based on ESTRO core curriculum. Possible answers: 
very low, low, intermediate, good, very good
1.	 Identify	the	technique	to	be	used	
2.	 Identify	the	patient	in	advance	and	be	familiar	with	their	
general	condition	
3.	 Evaluate	the	treatment	plan	
4.	 Identify	the	roles	and	responsibilities	of	the	members	of	
the	team	
5.	 Recognize	the	specific	radiation	hazards	associated	with	
brachytherapy	
6.	 Identify	the	routine	quality	assurance	(QA)	and	safety	
procedures	that	should	be	carried	out	prior	to	treatment	
7.	 Arrange	the	treatment	room	and	ensure	all	equipment	is	
available	
8.	 Assemble	all	the	documents	required	
9.	 Inform	the	patient	of	the	procedure	
10.	 If	appropriate,	participate	in	planning	the	treatment	
11.	 Manage	the	aspects	of	the	procedures	that	are	the	re-
sponsibility	of	the	RT	
12.	 Check	all	radiation	protection	requirements	have	been	
met	
13.	 Carry	out	the	routine	QA	and	safety	procedures	prior	to	
treatment	
14.	 Ability	to	recognize	and	perform	combined	treatments	
with	EBRT	
15.	 Ability	to	organize	and	perform	interdisciplinary	treat-
ments	
Table 3. Brachytherapy (BT) procedures in radiotherapy school
BT procedures Responders: available in the academic 
hospital or in the network  
(% of responders to the question)  
[% of the total participants to the survey] 
Responders: should be part of resident’s 
training  
(% of responders to the question)  
[% of the total participants to the survey] 
Total no. of  
responders
Gynecologic	 21	(95%)	[91%]	 13	(59%)	[57%]	 22	
Prostate	HDR	 4	(25%)	[17%]	 15	(94%)	[65%]	 16	
Prostate	LDR 6	(35%)	[26%]	 13	(77%)	[57%]	 17	
Skin	 14	(82%)	[61%]	 9	(53%)	[39%]	 17	
Breast	 8	(62%)	[35%]	 8	(62%)	[35%]	 13	
Esophagus	 9	(69%)	[39%]	 8	(62%)	[35%]	 13	
Head	and	neck	 8	(57%)	[35%]	 9	(64%)	[39%]	 14	
Lung	(endobronchial)	 8	(80%)	[35%]	 5	(50%)	[22%]	 10	
Sarcoma	 9	(53%)	[39%]	 12	(71%)	[52%]	 17	
Eye	 9	(60%)	[39%]	 8	(53%)	[35%]	 15	
Rectal	 7	(54%)	[30%]	 7	(54%)	[30%]	 13	
Anus	 12	(75%)	[52%]	 10	(63%)	[43%]	 16	
BT	in	children	 6	(60%)	[26%]	 5	(50%)	[22%]	 10	
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The most common types of BT education are: on site 
teaching (69%, 15 out of 22 responders), didactic lec-
tures (63%, 14 responders). Further modalities are: prob-
lem-based approaches (55%, 12 responders), on site do-
simetry teaching (46%, 10 responders), informal lectures 
(46%, 10 responders), case simulations (27%, 6 respond-
ers), courses (19%, 4 responders), and senior residents’ 
presentations (19%, 4 responders). 
About half (11 responders out of 23) of Italian residen-
tial schools have written specific objectives with respect 
to knowledge, skills, and required attitudes for a resident 
to be competent in BT. Three responders (13%) had these 
objectives specifically based on ESTRO core curriculum, 
and 5 additional responders (22%) were willing to rewrite 
the document according to the ESTRO core curriculum. 
The evaluation of practical skills of a resident was 
mostly carried out by oral examination (74%, 17 respond-
ers) or direct observation (65%, 15 responders), while 
sporadic cases of no formal evaluation (17%, 4 respond-
ers) and no written examinations were reported. 
The main barriers to BT education identified by SD 
were lack of clinical practice (63%, 12 responders), with 
a minority of SDs indicating lack of time as the reason 
(31%, 6 responders). Four SDs skipped the question and 
one (5%) answered that there are no main barriers. 
Almost all the skills indicated in ESTRO core curricu-
lum and listed in Table 2 were considered important and 
were acquired at an intermediate or higher level by the 
resident students. 
A question investigated which BT procedures are 
available and which of these should be part of the resi-
dent’s training, according to SDs. All Italian radiothera-
py schools offer BT procedures and training, but there is 
a wide heterogeneity. Details are shown in Table 3. 
Discussion 
The use of interventional radiotherapy (BT) has in-
creased in the last decades, most probably due to tech-
nical improvements, allowing to deliver higher doses to 
the target while reducing dose and volume of organs at 
risk [9]. Moreover, BT in Italy has been increasingly based 
on a multidisciplinary approach, with a growing num-
ber of high-quality publications of excellent treatment re-
sults [9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26, 
27,28,29,30,31]. These innovations, in the context of 
a rapid diffusion of 3D planning, with an increased use 
of computed tomography (CT), magnetic resonance im-
aging (MRI), positron emission tomography (PET)/CT, 
and ultrasound, favored the diffusion of image-guided 
brachytherapy (IGBT) [32] with related clinical benefits. 
The industry also played a central role in this process 
with the development of miniaturized sources (remote 
after loading HDR and PDR devices), and even smaller 
and better manageable applicators, CT/MRI-compatible 
[2]. The diffusion of dwelling devices paved the way to 
better treatment plans optimization (for both target cov-
erage and organs at risk [OARs] dose reduction). Inten-
sity modulated brachytherapy has become a reality [33]. 
These developments have led to an increased accuracy 
of the treatment and to the development of complex im-
age-based control systems of implant stability [2]. Better 
medical and physical quality assurance protocols have 
then been developed [34]. The use of intensity-modulat-
ed brachytherapy (IMBT) supported by IGBT has led to 
interesting clinical benefits, in terms of increased local 
control and decrease in toxicity [35,36,37,38,39,40,41,42, 
43,44]. On the other hand, the need to perform complex 
IGBT treatments has stimulated additional radiobiology 
research to introduce hypo-fractionated therapeutic pro-
tocols [2,45]. The introduction of ‘image fusion’ systems, 
self-control, dose optimization, and automatic catheter 
reconstruction represents another significant progress in 
planning procedures [46,47]. 
Analyzing the different kinds of BT procedures/sites 
treated, three major groups can be identified according to 
the survey results: 
1. Available and important for residential training (gy-
necologic, skin, anus, breast, esophagus, eye); the 
percentage of respondents perceiving the need for 
practical training (60-95%) is inferior or equals to the 
availability in the school network; 
2. Important but not sufficiently available (prostate, sar-
coma, head and neck); the percentage of respondents 
perceiving the need for practical training (53-94%) is 
superior or equals to the availability in the school net-
work (this is particularly evident in case of prostate 
cancer); 
3. Apparently less relevant for residential training (lung, 
BT in children, and rectal). 
To summarize, BT offers an important contribution in 
oncology for a variety of tumor sites [48]. Thus, the knowl-
edge of basic principles, indications, limiters, and possible 
integrations of BT with other treatment modalities should 
be an important part of the core curriculum of RO’s. The 
ESTRO core curriculum offers a good guidance to stan-
dardization and formalization of contents, but the main 
obstacle to set up an effective and high-level training in 
interventional BT is the lack of actual clinical practice. The 
central role of personal experience and procedural obser-
vation has been highlighted during the meeting. Due to 
the importance of practical skills requested by BT practice, 
a theoretical teaching could only partially replace on-site 
education. Direct observation of BT is the best way to learn 
indications/contraindications as well as procedures. The 
use of simulation or dummies can be another possibility 
of training, especially for rarer procedures. Although not 
all the board-certified ROs will practice BT in their pro-
fessional life, all of them should be aware when a patient 
profits from an interventional RT treatment. 
The present survey has some drawbacks: a) realized 
in two phases, b) obtained answers to the different ques-
tions from a variable number of respondents. However, 
the present status of BT teaching seems to clearly emerge 
from the data collected and herein presented. 
In fact, the present survey has evidenced a wide het-
erogeneity in practical learning activities available to 
trainees in radiation oncology across the country. Even 
if theoretical teaching is guaranteed, the types of practice 
to which trainees are exposed vary significantly among 
different schools. This is the reason why the survey re-
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sults have emphasized the need of standardization of 
the training system through the adoption of unified core 
curriculum. Italian law recently introduced an accredita-
tion system, enforcing strict quality assurance criteria for 
specialization schools [5,6]. However, the detailed defini-
tion of some learning objectives has been assigned to the 
individual local academic communities, thus leaving the 
basics for some teaching areas less precisely defined. 
Therefore, the results of the present survey and the 
fact that not all the RT schools can rely on adequate vol-
umes of procedures or on availability of experts for all the 
potential applications of BT, should be carefully consid-
ered. The opportunity of a geographically well-distribut-
ed network of learning sites organized by the residential 
schools has been therefore envisaged. A potential solu-
tion could also be to set up specific inter-University train-
ing courses (e.g., Masters) for ROs interested to acquire 
a specific expertise in BT. 
These University-certified learning courses could also 
help to select BT professionals’ services offered to health 
providers. Additionally, creating national/international 
technology transfer fellowships or supported attendance 
to national/international courses could serve as a part of 
a national educational programme. 
Conclusions 
This survey has evidenced the need for an improve-
ment of interventional radiotherapy (BT) education in Ita-
ly, especially to better define and harmonize programs at 
national level, particularly in practical teaching. The ES-
TRO core curriculum could be considered as a sound ba-
sis for the creation of a national BT education programme, 
based on a geographic network for BT practical teaching. 
Supporting the attendance of national and international 
courses on specific aspects of BT may also facilitate the 
achievement of a satisfying level of BT knowledge among 
RO’s. Finally, Universities may establish post-specialty 
courses (‘second level’ Masters) to allow professionals 
(already certified in radiation oncology) to acquire more 
complex BT knowledges. This could facilitate the recruit-
ment of skilled professionals for hospitals’ BT units. 
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